Thank you, Russell. Organic sales were led by growth of 4.3% in the Americas and Asia region, which was partially offset by a slight organic sales decline of 0.8% in our Europe and Australia region for total organic sales growth of 2.6% in the quarter. We also grew adjusted diluted earnings per share from $0.93 per share last Q2 to $1.00 per share this quarter, which was an increase of 7.5%. We took some actions in the quarter to address our cost structure in three specific areas in response to the performance of certain businesses as well as economic conditions. First, we announced the closure of our manufacturing facility in Beijing, China. Given the decline in economic activity in China as well as our sales decline, this plant closure will reduce our cost structure and our overall footprint in China. Second, we announced the closure of our manufacturing facility in Buffalo, New York. We have gradually reduced production within this facility over the last several years, and we plan to move the remaining product lines to our headquarters in Milwaukee. And third, we took actions to reorganize our overhead structure in Europe, which resulted in headcount reductions. Our goal with these actions is to operate with a more efficient reporting structure while further integrating the operations of our Gravitech acquisition. In total, we recognized facility closure and other reorganization costs of $5.7 million in the second quarter, and we believe these actions will allow us to operate more effectively and efficiently going forward. We'll start on slide number four, which details our quarterly sales trends. Organic sales grew 2.6% this quarter, acquisitions added 10.2%, and foreign currency translation reduced sales by 2.2% for total sales growth of 10.6% in the quarter. Slide number five details our quarterly gross margin trending. Our gross profit margin was 49.3% this quarter compared to 50.2% in the second quarter of last year. The facility closures in Beijing and Buffalo, New York that I just mentioned resulted in incremental expense of $2.3 million in the second quarter. Without this incremental expense, our gross profit margin would have been 50% this quarter, only 20 basis points below the second quarter of last year. Our gross profit margin continues to be strong as we realized benefits from our sales growth being led by higher gross profit margin products. Turning to slide number six, you'll find our SG&A expense trending. SG&A was $105.9 million this quarter compared to $91.3 million in the second quarter of last year. As a percent of sales, SG&A increased to 29.7% compared to 28.3% last Q2. If you exclude amortization expense of $4.7 million, and the facility closure and other reorganization costs of $3.4 million this quarter, SG&A would have been 27.4% of sales in the second quarter of this year compared to 27.6% in the second quarter of last year. As a percentage of sales, which would be a decrease of 20 basis points. We continue to identify efficiencies throughout our sales support function as well as other administrative support functions. Which allows us to continue to invest in growth by expanding our sales force, enhancing our digital capabilities, and broadening our omnichannel strategies. Slide number seven details the trending of our investments in research and development. We continue to increase our investments in R&D throughout Brady, and our R&D expense was $18.7 million this quarter. This was an increase of 11.2% from $16.8 million in last year's second quarter. As a percentage of sales, R&D was consistent at 5.2% in both periods. We continue to demonstrate our commitment to new product development with the launch of the I7500 being a prime example of the results of this increased investment. Turning to slide number eight, you'll find the trending of our pre-tax earnings. Pre-tax earnings on a GAAP basis decreased from $55.8 million to $52 million in the quarter. But if you exclude amortization from both periods, as well as the facility closure and other reorganization charges we incurred in the current quarter, pre-tax earnings increased 7.2% from $58.2 million to $62.4 million. On slide number nine, you'll find the trending of our net earnings and earnings per share. Our GAAP net income decreased due to the incremental asset amortization from our acquisitions as well as from the facility closure and other reorganization costs that we incurred in the quarter as previously mentioned. Our reported GAAP diluted earnings per share was $0.83 compared to $0.90 per share in the second quarter of last year. But if you exclude amortization from both periods, as well as the facility closure and other reorganization charges from the current period, our adjusted net income increased from $45.4 million to $48.1 million, which was an increase of 5.9%, and our adjusted diluted EPS increased from $0.93 per share to $1.00 per share, which was an increase of 7.5%. Turning to slide number ten, you'll find a summary of our cash generation. Operating cash flow was $39.6 million in the second quarter of this year, compared to $36.1 million in the second quarter of last year. Free cash flow was $32.5 million in Q2 of this year compared to a negative $13.5 million in last year's Q2. Capital expenditures were higher than normal last year due to the purchase of a previously leased facility along with the construction of a new facility. We expect our CapEx to return to a more normalized level this year, which is what you're seeing in our results. Slide number eleven details the impact that our historical cash generation has had on our balance sheet. As of January 31st, we were in a net cash position of $50.8 million, which was an increase of $21.7 million since the first quarter of this fiscal year. Our approach to capital allocation is consistent, which is first, use our cash to fund the organic sales growth and efficiency opportunities. This includes investing in new product development, sales-generating resources, and capability-enhancing CapEx. Our historically strong cash generation gives us the ability to invest throughout the economic cycle so that we're always positioned to drive future sales growth and improvement in profitability. And second, we focus on consistently increasing our dividends. This fiscal year, we announced our thirty-ninth consecutive year of annual dividend increases, which continues to be a streak that we're incredibly proud of. After funding organic investments and dividends, we then deploy our cash in a disciplined manner for acquisitions where the synergies are clear and for opportunistic share buybacks. Our balance sheet puts us in a position to be able to continue to increase our investment in organic sales opportunities, invest in new product development, acquire companies that are a strategic fit with our core business, and return funds to our shareholders through dividends and share buybacks. Slide number twelve details our fiscal 2025 guidance. We are increasing the low end of our full-year fiscal 2025 adjusted diluted EPS guidance range from $4.40 per share to $4.70 per share, and moving that range to $4.45 per share to $4.70 per share. Our GAAP EPS guidance range was updated for the facility closure and other reorganization charges incurred to date, and we now expect a GAAP EPS range of $3.99 per share to $4.24 per share. Our adjusted diluted EPS range represents a range of growth of between 5.5% to 11.4% compared to fiscal year 2024. We also anticipate organic sales growth in the low single-digit percentages for the year ending July 31, 2025. Other elements of our guidance include depreciation and amortization expense of approximately $40 million, capital expenditures of approximately $35 million, and we now expect a full-year income tax rate of approximately 21%. Our income tax rate generally tends to be slightly lower in the fourth quarter than our full-year expectations based upon our historical profit mix and the expected timing of other discrete adjustments. Potential risks to our guidance, among others, include potential strengthening of the US dollar, inflationary pressures that we're unable to offset in a timely enough manner, or an overall slowdown in economic activity. I'll turn the call back over to Russell to cover our regional results and provide some closing thoughts before Q&A.